Evommune, Inc. (EVMN) — Long-term Investment Intensity

Latest as of December 2025: 30.0%

Evommune, Inc. (EVMN) has a Long-term Investment Intensity of 30.0% as of December 2025. Long-term investments of $67.49 Million represent 30.0% of total assets of $224.95 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore Evommune, Inc. (EVMN) cash conversion ratio to assess how effectively this company generates cash.

LT Investment Intensity

30.0%
LT Investments / Total Assets

Long-term Investments

$67.49 Million
USD

Total Assets

$224.95 Million
USD

Country

USA
NYSE

Evommune, Inc. Long-term Investment Intensity (2025–2025)

This chart shows how Evommune, Inc.'s Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of December 2025, the intensity stands at 30.0%, reflecting long-term investments of $67.49 Million against total assets of $224.95 Million USD. Explore how well can Evommune, Inc. service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for Evommune, Inc. (2025–2025)

The table below presents the year-by-year Long-term Investment Intensity for Evommune, Inc. from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Evommune, Inc. (EVMN) market capitalisation.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 30.0% $67.49 Million $224.95 Million
pp = percentage points